Role of p53 in the Regulation of Cellular Senescence
Open accessThe DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
Abstract
The p53 transcription factor plays a critical role in cellular responses to stress. Its activation in response to DNA damage leads to cell growth arrest, allowing for DNA repair, or directs cellular senescence or apoptosis, thereby maintaining genome integrity. Senescence is a permanent cell-cycle arrest that has a crucial role in aging, and it also represents a robust physiological antitumor response, which counteracts oncogenic insults. In addition, senescent cells can also negatively impact the surrounding tissue microenvironment and the neighboring cells by secreting pro-inflammatory cytokines, ultimately triggering tissue dysfunction and/or unfavorable outcomes. This review focuses on the characteristics of senescence and on the recent advances in the contribution of p53 to cellular senescence. Moreover, we also discuss the p53-mediated regulation of several pathophysiological microenvironments that could be associated with senescence and its development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Induction and initiation of cellular growth control and senescence via p53 or P16INK4A pathways. Various internal or external stress factors trigger the DNA-damage response (DDR) pathway, which in turn activates the p53 and/or the p16INK4A pathways. p16INK4A inactivates Cdk4/6, results in accumulation of phosphorylated pRb, stops the regulation of E2F transcription factors, and drives cell cycle arrest or senescence. These stressors also trigger DNA damage (cellular responses to such damages are regulated by either ATM-Chk2 or ATR-Chk1 pathways) and transactivate p53 and p21CIP1. Moreover, p21CIP1 protein levels may lead to the inhibition of Cdk4/6 activity, which contribute to the G1 arrest or senescence [33,34].](https://figures.cochat.ai/paper-figures/73d1c8e4b31243a49a8fdf24b567946a/role-of-p53-in-the-regulation-of-cellular-senescence-figure-1.jpg)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Senescence is driven by the tumor-suppressor pathways p53-p21CIP1 and p16INK4a-Rb,19,20,21”
From Cellular senescence in human liver under normal aging and cancer (2026) · cites this paper as [19]
The cited source says what the claim attributes to it.
In the citing paper
“with CDKN2A (p16INK4a) and CDKN1A (p21CIP1) serving as canonical senescence markers.”
From Cellular senescence in human liver under normal aging and cancer (2026) · cites this paper as [19]
In the citing paper
“The p16INK4A/Rb pathway also plays a critical role in senescence. CDK4/6 are inactivated by p16INK4A, promoting the accumulation of phosphorylated Rb and the inactivation of E2F transcription, which induces senescence.66”
From p53: from understanding its structure to advances in therapeutic targeting (2026) · cites this paper as [66]
In the citing paper
“p16INK4A inactivates Cdk4/6, phosphorylates Rb accumulation and inactivates E2F transcription, leading to cell cycle arrest or senescence.85”
From Targeting p53 pathways: mechanisms, structures, and advances in therapy (2023) · cites this paper as [85]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
The senescence-associated secretory phenotype: the dark side of tumor suppression
Coppé, J.-P., Desprez, P.-Y., Krtolica, A., & Campisi, J. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102144 · Cited by 5,206 · cited 1×
“Cellular senescence is a physiological mechanism adopted by cells to limit tumorigenesis [99,100], and for this reason, a therapy-induced senescence was considered as an alternative and possibly safer approach to the traditional cancer therapy, which aimed at inducing extensive DNA damage [101].”
BackgroundInflammatory responses and inflammation-associated diseases in organs
Chen, L., Deng, H., Cui, H., Fang, J., Zuo, Z., Deng, J., Li, Y., Wang, X., & Zhao, L. (2018) · Oncotarget · doi:10.18632/oncotarget.23208 · Cited by 5,143 · cited 1×
“It is responsible for many chronic diseases, including cardiovascular and bowel diseases, diabetes, arthritis, and cancer [114,115].”
BackgroundIn Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661 · cited 2×
“Many recent studies actually demonstrated how many OIS pathways can actually activate p53 bypassing the DDR: Ras through NOREA1, which promotes the pro-senescence acetylation of p53 while inhibiting its pro-apoptotic phosphorylation, AKT through the downregulation of MnSOD, onco-suppressor PTEN depletion, inducing mTO…”
BackgroundCellular Senescence: Defining a Path Forward
Gorgoulis, V., Adams, P. D., Alimonti, A., Bennett, D. C., Bischof, O., Bishop, C., Campisi, J., Collado, M., Evangelou, K., Ferbeyre, G., et al. (2019) · Cell · doi:10.1016/j.cell.2019.10.005 · Cited by 3,225 · cited 2×
“Cellular senescence is defined as a cell state characterized by prolonged and generally irreversible cell-cycle arrest [14] and the acquisition of different phenotypic alterations, including morphological changes, chromatin remodeling, metabolic reprogramming, and secretion of pro-inflammatory factors or SASP (senesce…”
BackgroundBlinded by the Light: The Growing Complexity of p53
Vousden, K. H., & Prives, C. (2009) · Cell · doi:10.1016/j.cell.2009.04.037 · Cited by 3,163 · cited 1×
“This impressive number is a reflection of the many—sometimes alternative—roles p53 can play; in fact, several of these genes are known to be involved in the regulation of metabolism, autophagy, DNA damage repair, cell cycle arrest, quiescence, senescence, and apoptosis [35].”
BackgroundThe role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623
Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,379 · cited 1×
“However, once p16 is highly expressed, downregulation of p53 cannot reverse cell cycle arrest [58].”
BackgroundCellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363 · cited 1×
“Stressors include both intrinsic factors, such as oxidative damage, telomere attrition, hyperproliferation, oncogene activation, and environmental sources, including UV-light, γ-irradiation, and chemotherapeutic drugs [18,19].”
BackgroundOncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086 · cited 1×
“They also reported co-localization of IL-8 and senescence markers in human colon adenomas [42].”
Background
Cited by
Targeting p53 pathways: mechanisms, structures, and advances in therapy
Wang, H., Guo, M., Wei, H., & Chen, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01347-1 · Cited by 1,016
“p16INK4A inactivates Cdk4/6, phosphorylates Rb accumulation and inactivates E2F transcription, leading to cell cycle arrest or senescence.(85) Alternatively, when UV-induced DNA damage occurs, ATM/ATR activates Chk1/Chk2 kinase, which further activates p53 and p21, leading to G1 arrest or senescence.”
BackgroundTargeting cellular senescence with senotherapeutics: senolytics and senomorphics
Zhang, L., Pitcher, L. E., Prahalad, V., Niedernhofer, L. J., & Robbins, P. D. (2023) · The FEBS Journal · doi:10.1111/febs.16350 · Cited by 621
p53 signaling in cancer progression and therapy
Marei, H. E., Althani, A., Afifi, N., Hasan, A., Caceci, T., Pozzoli, G., Morrione, A., Giordano, A., & Cenciarelli, C. (2021) · Cancer Cell International · doi:10.1186/s12935-021-02396-8 · Cited by 588
Self-citationFerroptosis, radiotherapy, and combination therapeutic strategies
Lei, G., Mao, C., Yan, Y., Zhuang, L., & Gan, B. (2021) · Protein & Cell · doi:10.1007/s13238-021-00841-y · Cited by 504
ROS: Basic Concepts, Sources, Cellular Signaling, and its Implications in Aging Pathways
de Almeida, A. J. P. O., de Oliveira, J. C. P. L., da Silva Pontes, L. V., de Souza Júnior, J. F., Gonçalves, T. A. F., Dantas, S. H., de Almeida Feitosa, M. S., Silva, A. O., & de Medeiros, I. A. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/1225578 · Cited by 474
“Oxidative stress can induce DDR directly or indirectly by several pathways and, consequently, the activation of p53/p21 and p16/pRB pathways [288].”
BackgroundCai, Y., Song, W., Li, J., Jing, Y., Liang, C., Zhang, L., Zhang, X., Zhang, W., Liu, B., An, Y., et al. (2022) · Science China Life Sciences · doi:10.1007/s11427-022-2161-3 · Cited by 408
Riegger, J., Schoppa, A., Ruths, L., Haffner-Luntzer, M., & Ignatius, A. (2023) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-023-00489-y · Cited by 235
Cadmium Exposure: Mechanisms and Pathways of Toxicity and Implications for Human Health
Qu, F., & Zheng, W. (2024) · Toxics · doi:10.3390/toxics12060388 · Cited by 235
“…plays a vital role in helping cells respond to DNA damage and other stress conditions by maintaining cellular genetic stability and preventing cancerous transformations through multiple downstream effector pathways, including cell-cycle arrest, apoptosis, DNA repair, and cellular senescence [66].”
BackgroundRole of p53 in breast cancer progression: An insight into p53 targeted therapy
Marvalim, C., Datta, A., & Lee, S. C. (2023) · Theranostics · doi:10.7150/thno.81847 · Cited by 225
Silwal, P., Nguyen-Thai, A. M., Mohammad, H. A., Wang, Y., Robbins, P. D., Lee, J. Y., & Vo, N. V. (2023) · Biomolecules · doi:10.3390/biom13040686 · Cited by 210
“It has been reported that the p53-p2CIP1 pathway plays a major role in initiation of senescence while the p16INK4a-Rb pathway is required for stable cell cycle arrest and senescence [78].”
BackgroundGDF15, an emerging key player in human aging
Conte, M., Giuliani, C., Chiariello, A., Iannuzzi, V., Franceschi, C., & Salvioli, S. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101569 · Cited by 186
Basu, A. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107943 · Cited by 171
Heavy Metal Exposure: Molecular Pathways, Clinical Implications, and Protective Strategies
Koyama, H., Kamogashira, T., & Yamasoba, T. (2024) · Antioxidants · doi:10.3390/antiox13010076 · Cited by 201
“Heavy metal exposure impairs the p16/p21/p53 transcription pathway, which plays a critical role in cellular stress responses [98].”
Cox, F. F., Misiou, A., Vierkant, A., Ale‐Agha, N., Grandoch, M., Haendeler, J., & Altschmied, J. (2022) · Cells · doi:10.3390/cells11030342 · Cited by 163
“One hallmark of aging is cellular senescence, a state of cell cycle arrest, triggered in part by the p53/Cyclin-dependent kinase inhibitor 1A (CDKN1A or p21) pathway [54].”
BackgroundLee, J., & Lee, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094843 · Cited by 172
The regulatory roles of p53 in cardiovascular health and disease
Men, H., Cai, H., Cheng, Q., Zhou, W., Wang, X., Huang, S., Zheng, Y., & Cai, L. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03694-6 · Cited by 137
CDK4/6 inhibitors induce replication stress to cause long‐term cell cycle withdrawal
Crozier, L., Foy, R., Mouery, B. L., Whitaker, R. H., Corno, A., Spanos, C., Ly, T., Gowen Cook, J., & Saurin, A. T. (2022) · The EMBO Journal · doi:10.15252/embj.2021108599 · Cited by 134
“However, it could also block senescence entry (Mijit et al , 2020) and enhance heterogeneity, thereby increasing the chances of immune evasion.”
Dileep, V., Boix, C. A., Mathys, H., Marco, A., Welch, G. M., Meharena, H. S., Loon, A., Jeloka, R., Peng, Z., Bennett, D. A., et al. (2023) · Cell · doi:10.1016/j.cell.2023.08.038 · Cited by 130
“72 Similar to our observations from BLISS in CK-p25, human fusion genes in excitatory neurons also tended to have increased gene expression in both AD and control individuals (Figure 2E).”
ResultXiang, X., Fu, Y., Zhao, K., Miao, R., Zhang, X., Ma, X., Liu, C., Zhang, N., & Qu, K. (2021) · Theranostics · doi:10.7150/thno.55672 · Cited by 131
“In general, there are two types of senescence, replicative senescence (RS) caused by telomere shortening or dysfunction [2, 3] and premature senescence triggered by stress, including oncogenes (oncogene-induced senescence, OIS) [4, 5] and DNA damage response (DDR) [6].”
BackgroundCellular Senescence as the Pathogenic Hub of Diabetes-Related Wound Chronicity
Berlanga‐Acosta, J., Guillén, G. E., Rodríguez-Rodríguez, N., Mendoza‐Marí, Y., Bringas-Vega, M. L., Berlanga-Saez, J. O., Herrera, D. G. D. B., Martínez-Jiménez, I., Hernandez-Gutierrez, S., & Valdes-Sosa, P. A. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.573032 · Cited by 131
“Moreover, convergent lines of evidence point to the role played by p53 in the regulation of cell cycle arrest and senescence (50, 76, 77).”
BackgroundRecent advances in the discovery of senolytics
Zhang, L., Pitcher, L. E., Prahalad, V., Niedernhofer, L. J., & Robbins, P. D. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111587 · Cited by 115
Targeting senescence as an anticancer therapy
Bousset, L., & Gil, J. (2022) · Molecular Oncology · doi:10.1002/1878-0261.13312 · Cited by 105
Cardiac cell senescence: molecular mechanisms, key proteins and therapeutic targets
Luan, Y., Zhu, X., Jiao, Y., Liu, H., Huang, Z., Pei, J., Xu, Y., Yang, Y., & Ren, K. (2024) · Cell Death Discovery · doi:10.1038/s41420-023-01792-5 · Cited by 122
“3) [29].”
BackgroundZhang, X., Liu, X., Du, Z., Wei, L., Fang, H., Dong, Q., Niu, J., Li, Y., Gao, J., Zhang, M. Q., et al. (2021) · Genome Research · doi:10.1101/gr.275235.121 · Cited by 99
“Cellular senescence is stable cell cycle arrest that can be triggered by exogenous or endogenous stresses (vanDeursen 2014) and contributes to tissue remodeling and age-related diseases, including cancer (Campisi 2013; Muñoz-Espín et al. 2013; van Deursen 2014).”
BackgroundOf the many cellular responses activated by TP53, which ones are critical for tumour suppression?
Thomas, A., Kelly, G. L., & Strasser, A. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-00996-z · Cited by 110
Alzheimer’s Disease and Inflammaging
Kosyreva, A., Sentyabreva, A., Tsvetkov, I., & Makarova, O. (2022) · Brain Sciences · doi:10.3390/brainsci12091237 · Cited by 98
“This process is accompanied by abrupt changes in cell size, shape, and vacuolization of the cytoplasm, as well as functional properties, including an impaired rate of decline, rearrangement of the nucleus and chromatin, and resistance to the apoptosis signal [13].”
BackgroundUbiquitin-Specific Proteases: Players in Cancer Cellular Processes
Cruz, L. L., Soares, P., & Correia, M. (2021) · Pharmaceuticals · doi:10.3390/ph14090848 · Cited by 107
Rahman, M. A., Park, M. N., Rahman, M. H., Rashid, M. M., Islam, R., Uddin, M. J., Hannan, M. A., & Kim, B. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.761080 · Cited by 99
Wong-Guerra, M., Calfío, C., Maccioni, R. B., & Rojo, L. E. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1161850 · Cited by 103
Senescence of alveolar epithelial progenitor cells: a critical driver of lung fibrosis
Parimon, T., Chen, P., Stripp, B. R., Liang, J., Jiang, D., Noble, P. W., Parks, W. C., & Yao, C. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00239.2023 · Cited by 110
Ketogenic diet induces p53-dependent cellular senescence in multiple organs
Wei, S.-J., Schell, J. R., Chocron, E. S., Varmazyad, M., Xu, G., Chen, W. H., Martinez, G. M., Dong, F. F., Sreenivas, P., Trevino, R., et al. (2024) · Science Advances · doi:10.1126/sciadv.ado1463 · Cited by 87
“A KD induces markers of the SASP Senescent cells can adversely affect adjacent cells and the tissue microenvironment by secreting pro-inflammatory cytokines ( 37 ).”
Zhang, H., Xu, J., Long, Y., Maimaitijiang, A., Su, Z., Li, W., & Li, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312928 · Cited by 108
Nan, L., Guo, P., Hui, W., Xia, F., & Yi, C. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1592596 · Cited by 84
“Additionally, activation of p53 (TP53) in response to DNA damage contributes to the upregulation of p21, reinforcing senescence onset (Jin et al., 2024; Mijit et al., 2020).”
DNA Damage-Induced Inflammatory Microenvironment and Adult Stem Cell Response
Cinat, D., Coppes, R. P., & Barazzuol, L. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.729136 · Cited by 81
“Moreover, p53 plays a central role in the DDR and its activity is essential for the prevention of cancer development by promoting cell death and senescence (Mijit et al., 2020).”
BackgroundThe p53 family member p73 in the regulation of cell stress response
Rozenberg, J. M., Zvereva, S. D., Dalina, A. A., Blatov, I., Zubarev, I. V., Luppov, D. V., Bessmertnyi, A., Romanishin, A. O., Alsoulaiman, L., Kumeiko, V. V., et al. (2021) · Biology Direct · doi:10.1186/s13062-021-00307-5 · Cited by 91
Khavinson, V., Linkova, N. S., Dyatlova, A., Кантемирова, Р. К., & Kozlov, K. L. (2022) · Cells · doi:10.3390/cells12010106 · Cited by 88
Farzaneh, Z., Vosough, M., Agarwal, T., & Farzaneh, M. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01924-w · Cited by 89
“P53 is crucial for cell cycle arrest, cell senescence, and cell autophagy [153, 154].”
BackgroundMuthamil, S., Kim, H., Jang, H., Lyu, J., Shin, U. C., Go, Y., Park, S., Lee, H. G., & Park, J. H. (2024) · Advanced Biology · doi:10.1002/adbi.202400079 · Cited by 98
Oxidative Stress-Driven Cellular Senescence: Mechanistic Crosstalk and Therapeutic Horizons
Stojanović, B., Jovanovic, I., Stojanovic, M. D., Stojanović, B., Kovačević, V., Radosavljević, I., Jovanović, D., Kovačević, M. M., Zornić, N., Arsić, A. A., et al. (2025) · Antioxidants · doi:10.3390/antiox14080987 · Cited by 115
“This leads to the stabilization of p53 and the transcriptional upregulation of cyclin-dependent kinase inhibitors such as p21 CIP1 and p16 INK4a , culminating in durable growth arrest and the formation of SAHF [128–130].”
The Emergence of Senescent Surface Biomarkers as Senotherapeutic Targets
Rossi, M., & Abdelmohsen, K. (2021) · Cells · doi:10.3390/cells10071740 · Cited by 71
“Interestingly, the p16/RB pathway seems to be involved in the long-term maintenance of cellular senescence, whereas the p53/p21 pathway seems to play a key role in the initiation phase of senescence, as suggested by a frequent decrease observed in p53 and p21 levels in late senescence [31].”
BackgroundInfluentialSplicing alterations in healthy aging and disease
Angarola, B. L., & Anczuków, O. (2021) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1643 · Cited by 83
“The tumor suppressor protein p53, encoded by the TP53 gene, plays a critical role in regulating targets in several critical pathways including cell cycle arrest, DNA repair, apoptosis, and cellular senescence (Mijit et al., 2020).”
BackgroundTherapeutic targeting of senescent cells in the CNS
Riessland, M., Ximerakis, M., Jarjour, A. A., Zhang, B., & Orr, M. E. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-024-01033-z · Cited by 77
“…with Parkinson disease, as well as in Parkinson disease animal and cellular models, mostly correlating with DNA damage 124 . p53-dependent brain senescence has also been reported in Huntington disease and AD 124 , suggesting that p53 may be an especially appealing target for CNS senescence.”
Situmorang, P. C., Ilyas, S., Nugraha, S. E., Syahputra, R. A., & Rahman, N. M. A. N. A. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1387866 · Cited by 84
TP53 in Biology and Treatment of Osteosarcoma
Synoradzki, K. J., Bartnik, E., Czarnecka, A. M., Fiedorowicz, M., Firlej, W., Brodziak, A., Stasinska, A., Rutkowski, P. L., & Grieb, P. (2021) · Cancers · doi:10.3390/cancers13174284 · Cited by 70
Akt Isoforms: A Family Affair in Breast Cancer
Basu, A., & Lambring, C. B. (2021) · Cancers · doi:10.3390/cancers13143445 · Cited by 67
“On the other hand, the CDK2 inhibitor p21, a transcriptional target of the tumor suppressor protein p53 which halts cell cycle in response to DNA damage or cellular stress, can trigger senescence [124].”
BackgroundDańczak‐Pazdrowska, A., Gornowicz‐Porowska, J., Polańska, A., Krajka‐Kuźniak, V., Stawny, M., Gostyńska, A., Rubiś, B., Noureddine, S. A., Ashiqueali, S., Schneider, A., et al. (2023) · Aging Cell · doi:10.1111/acel.13845 · Cited by 71
“Recently, the role of p53, which regulates cell cycle arrest, DNA repair, and apoptosis, has been linked to inducing cellular senescence secondary to loss of p53 function and chromosomal instability (Mijit et al., 2020).”
BackgroundTargeting Cellular Senescence for Healthy Aging: Advances in Senolytics and Senomorphics
Alum, E., Izah, S., Uti, D., Ugwu, O., Betiang, P., Basajja, M., & Ejemot-Nwadiaro, R. (2025) · Drug Design, Development and Therapy · doi:10.2147/dddt.s543211 · Cited by 63
“…senescence is often triggered by DNA damage, which activates the DNA damage response (DDR) and key regulatory pathways such as p53/p21 and p16INK4a/Rb. 55 While these pathways prevent damaged cells from proliferating, they also promote inflammation and tissue dysfunction if senescent cells persist.”
Reactive and Senescent Astroglial Phenotypes as Hallmarks of Brain Pathologies
Lazic, A., Balint, V., Ninković, D. S., Perić, M., & Stevanović, M. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094995 · Cited by 65
Endothelial Cell Senescence Effect on the Blood-Brain Barrier in Stroke and Cognitive Impairment
Real, M. G. C., Falcione, S. R., Boghozian, R., Clarke, M., Todoran, R., Pierre, A. S., Zhang, Y., Joy, T., & Jickling, G. C. (2024) · Neurology · doi:10.1212/wnl.0000000000210063 · Cited by 70
Awad, H. H., Desouky, M. A., Zidan, A., Bassem, M., Qasem, A., Farouk, M., AlDeab, H., Fouad, M., Hany, C., Basem, N., et al. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01287-w · Cited by 59
“Importantly, p53 is one of the well-established senescence-associated markers owning to its ability to orchestrate many downstream targets that regulate cell cycle arrest and apoptosis (Mijit et al. 2020).”
BackgroundLawrence, M., Goyal, A., Pathak, S., & Ganguly, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137411 · Cited by 63
“Consequently, this prevents cell cycle progression by inducing G1arrest and G2/M [74,76,77].”
BackgroundPeriodontal Disease and Senescent Cells: New Players for an Old Oral Health Problem?
Aquino-Martínez, R., Khosla, S., Farr, J. N., & Monroe, D. G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207441 · Cited by 66
“A key downstream target of DDR is p53 that constitutes a barrier against tumor progression [73].”
BackgroundFan, X., He, Y., Wu, G., Chen, H., Cheng, X., Zhan, Y., An, C., Chen, T., & Wang, X. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2022.119411 · Cited by 58
An update in club cell biology and its potential relevance to chronic obstructive pulmonary disease
Blackburn, J. B., Li, N. F., Bartlett, N. W., & Richmond, B. W. (2023) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00192.2022 · Cited by 59
Adem, Y., Galderisi, U., & Alessio, N. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1148761 · Cited by 57
“Upregulated expressions of these genes and detection of their downstream products in conditioned media of senescent cell populations usually correlated with the alteration of cell cycles, growth arrest, and occurrence of senescent cells in the heterogeneous population of MSC cells (Mijit et al., 2020; Kumari and Jat,…”
BackgroundGungor, M. Z., Uysal, M., & Şentürk, Ş. (2022) · Cancers · doi:10.3390/cancers14040940 · Cited by 58
“Therefore, consistent with the proposed role of p53 in premalignant tumors, the loss of p53-mediated surveillance mechanisms could permit evasion of cellular senescence and promote progression into a malignant phenotype [84,89].”
BackgroundAdaptive homeostasis and the p53 isoform network
Mehta, S., Campbell, H., Drummond, C. J., Li, K., Murray, K., Slatter, T., Bourdon, J., & Braithwaite, A. W. (2021) · EMBO reports · doi:10.15252/embr.202153085 · Cited by 49
Singh, S. P., Bhaskar, R., Ghosh, S., Yarlagadda, B., Singh, K. K., Verma, P., Sengupta, S., Mladenov, M. I., Hadzi‐Petrushev, N., Stojchevski, R., et al. (2025) · Cancers · doi:10.3390/cancers17071082 · Cited by 69
“The third one is cellular senescence, which stops the proliferation of damaged cells [82,83].”
Gastrodiae rhizoma attenuates brain aging via promoting neuritogenesis and neurodifferentiation
Hsu, W., Huang, N., Shiao, Y., Lu, C., Chao, Y., Huang, Y.-J., Yeh, C. C., & Lin, Y. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153576 · Cited by 51
Wolfrum, P., Fietz, A., Schnichels, S., & Hurst, J. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1029473 · Cited by 57
“Thereby again, depending on various factors, the p53 mediated signaltransduction can either lead to the survival of the cell via cell cycle arrest and consecutive DNA repair mechanisms, the permanent cell cycle arrest via senescence or the lethal cell death via apoptosis (Mijit et al., 2020).”
BackgroundChen, D., Wang, J., Li, Y., Xu, C., Meng, F., Zhang, P., & Liu, L. (2023) · Clinical and Translational Medicine · doi:10.1002/ctm2.1418 · Cited by 48
Nunes-Pinto, M., de Mello, R. G. B., Pinto, M. N., Moro, C., Vellas, B. J., Martinez, L. O., Rolland, Y., & Barreto, P. D. S. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102587 · Cited by 60
Senescent cells limit p53 activity via multiple mechanisms to remain viable
Sturmlechner, I., Sine, C. C., Jeganathan, K. B., Zhang, C., Fierro Velasco, R. O., Baker, D. J., Li, H., & van Deursen, J. M. (2022) · Nature Communications · doi:10.1038/s41467-022-31239-x · Cited by 45
Cellular senescence in neuroinflammatory disease: new therapies for old cells?
Nelke, C., Schroeter, C. B., Pawlitzki, M., Meuth, S. G., & Ruck, T. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.07.003 · Cited by 51
Proteostasis disruption and senescence in Alzheimer’s disease pathways to neurodegeneration
Thapa, R., Bhat, A. A., Shahwan, M. J., Ali, H., Padmapriya, G., Bansal, P., Rajotiya, S., Barwal, A., Prasad, G. V. S., Pramanik, A., et al. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149202 · Cited by 54
Keeping zombies alive: The ER-mitochondria Ca2+ transfer in cellular senescence
Ahumada-Castro, U., Puebla-Huerta, A., Cuevas-Espinoza, V., Lovy, A., & Cárdenas, C. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.119099 · Cited by 47
Cellular mechanisms in brain aging: Focus on physiological and pathological aging
Aguilar‐Hernández, L., Alejandre‐Aguilar, R., Morales‐Medina, J. C., Iannitti, T., & Flores, G. (2022) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2022.102210 · Cited by 47
Cellular senescence and the blood–brain barrier: Implications for aging and age-related diseases
Knopp, R. C., Erickson, M. A., Rhea, E. M., Reed, M. J., & Banks, W. A. (2023) · Experimental Biology and Medicine · doi:10.1177/15353702231157917 · Cited by 48
Radiotherapy-induced ferroptosis for cancer treatment
Beretta, G. L., & Zaffaroni, N. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1216733 · Cited by 47
“, FAS/CD95, DR5, FAS ligands and caspase-8) rather than senescence (Sheikh and Fornace, 2000; Aubrey et al., 2018; Mijit et al., 2020).”
BackgroundJacczak, B., Rubiś, B., & Totoń, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126381 · Cited by 50
“p16, a cyclin/cdk inhibitor, pr vents phosphorylation of Rb by cyclin/cdk complexes [22].”
BackgroundKorfei, M., MacKenzie, B., & Meiners, S. (2020) · European Respiratory Review · doi:10.1183/16000617.0126-2020 · Cited by 45
Wang, R., Sun, L., Xia, S., Wu, H., Ma, Y., Zhan, S., Zhang, G., Zhang, X., Shi, T., & Chen, W. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03736-2 · Cited by 44
Lee, K., Ho, S., Sun, W.-L., Feng, P., Lin, C., Chen, K.-Y., Chuang, H., Tseng, C., Chen, T.-T., & Wu, S. (2022) · Cell Biology and Toxicology · doi:10.1007/s10565-022-09709-1 · Cited by 41
Senescence, NK cells, and cancer: navigating the crossroads of aging and disease
Gergues, M., Bari, R., Koppisetti, S., Gosiewska, A., Kang, L., & HARIRI, R. J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1565278 · Cited by 51
“Its expression is associated with stabilizing the senescent state through the prevention of phosphorylation of Rb. Additionally, the p53 tumor suppressor and its transcriptional target p21 are pivotal in inducing and maintaining senescence, particularly in response to DNA damage (87).”
Talebi, M., Talebi, M., Kakouri, E., Farkhondeh, T., Pourbagher‐Shahri, A. M., Tarantilis, P. Α., & Samarghandian, S. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.01.042 · Cited by 46
Vodicka, P., Andera, L., Opattova, A., & Vodickova, L. (2021) · Cancers · doi:10.3390/cancers13030479 · Cited by 39
“However, p53 also actively participates in the process of cellular senescence, which is relevant in the initial stages of carcinogenesis as an anti-cancer intervention together with the activation of the adaptive immune system and T cell-mediated elimination of senescent precancerous cells [35].”
BackgroundApigenin in cancer therapy: Prevention of genomic instability and anticancer mechanisms
Moslehi, M., Rezaei, S., Talebzadeh, P., Ansari, M. J., Jawad, M. A., Jalil, A., Rastegar-Pouyani, N., Jafarzadeh, E., Taeb, S., & Najafi, M. (2022) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13725 · Cited by 36
On the role of p53 in the cellular response to aneuploidy
Narkar, A., Johnson, B. A., Bharne, P., Zhu, J., Padmanaban, V., Biswas, D., Fraser, A. K., Iglesias, P. A., Ewald, A. J., & Li, R. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108892 · Cited by 34
The Kindlin2-p53-SerpinB2 signaling axis is required for cellular senescence in breast cancer
Sossey‐Alaoui, K., Pluskota, E., Szpak, D., & Plow, E. F. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1774-z · Cited by 38
The Ubiquitin Proteasome System and Skin Fibrosis
Shen, W., Zhang, Z., Ma, J., Lü, D., & Lyu, L. (2021) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-020-00509-z · Cited by 37
Cell Survival, Death, and Proliferation in Senescent and Cancer Cells: the Role of (Poly)phenols
Sorrenti, V., Buriani, A., Fortinguerra, S., Davinelli, S., Scapagnini, G., Cassidy, A., & Vivo, I. D. (2023) · Advances in Nutrition · doi:10.1016/j.advnut.2023.05.014 · Cited by 39
“These target genes are involved in the regulation of DNA damage repair, autophagy, metabolism, cell cycle arrest, quiescence, senescence, and apoptosis [66].”
BackgroundInfluentialAshiqueali, S., Chaudhari, D. S., Zhu, X., Noureddine, S. A., Siddiqi, S., Garcia, D. N., Gostyńska, A., Stawny, M., Rubis, B., Zanini, B. M., et al. (2024) · GeroScience · doi:10.1007/s11357-024-01060-z · Cited by 43
“Similarly, the downward trend of p16 Ink4a in the DSS + Fise-tin group suggests that Fisetin inhibits cellular senescence caused by DSS exposure [25, 26].”
InfluentialNew insights into methods to measure biological age: a literature review
Mathur, A., Taurin, S., & Alshammary, S. (2024) · Frontiers in Aging · doi:10.3389/fragi.2024.1395649 · Cited by 55
Heme Oxygenase-1 in Central Nervous System Malignancies
Sferrazzo, G., Rosa, M. D., Barone, E., Volti, G. L., Musso, N., Tibullo, D., & Barbagallo, I. A. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9051562 · Cited by 36
mTOR as a senescence manipulation target: A forked road
(2021) · Advances in Cancer Research · doi:10.1016/bs.acr.2021.02.002 · Cited by 35
Endothelial and systemic upregulation of miR-34a-5p fine-tunes senescence in progeria
Manakanatas, C., Ghadge, S. K., Agic, A., Sarigol, F., Fichtinger, P., Fischer, I., Foisner, R., & Osmanagic‐Myers, S. (2022) · Aging · doi:10.18632/aging.203820 · Cited by 38
“Persistent and high levels of p16 lead to irreversible permanent cell cycle arrest [11].”
BackgroundAn overview of the functions of p53 and drugs acting either on wild- or mutant-type p53
Huang, Y., Jiao, Z., Fu, Y., Hou, Y., Sun, J., Hu, F., Yu, S., Gong, K., Liu, Y., & Zhao, G. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116121 · Cited by 35
Fang, T., Wang, J., Sun, S., Deng, X., Xue, M., Han, F., Sun, B., & Chen, L. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155659 · Cited by 39
Prach, T., Feng, X., Zhang, K., & Hadjab, S. (2024) · Nature Communications · doi:10.1038/s41467-024-52052-8 · Cited by 45
“The presence of these genes together strongly suggested a process of cellular senescence during pain chroni fi cation 29 – 31 .”
Graziani, S., Scorrano, L., & Pontarin, G. (2022) · Cells · doi:10.3390/cells11020210 · Cited by 37
“Interestingly, p21 is a CDK inhibitor required for p53-induced cell cycle arrest and an inducer of senescence [16], lending further support to our earlier observation of Dox-induced senescence.”
BackgroundSalama, A., Yassen, N. N., & Mansour, H. M. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.121471 · Cited by 36
Hansel, C., Barr, S., Schemann, A. V., Lauber, K., Hess, J., Unger, K., Zitzelsberger, H., Jendrossek, V., & Klein, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22137064 · Cited by 33
“p53 itself could even directly impact on the cell’s fate towards a senescence phenotype as mediated by pro-senescence acetylation of p53 while pro-apoptotic phosphorylation was inhibited [49,51].”
BackgroundInflammation-Driven Genomic Instability: A Pathway to Cancer Development and Therapy Resistance
Rembiałkowska, N., Kocik, Z., Kłosińska, A., Kübler, M., Pałkiewicz, A., Rozmus, W., Sędzik, M., Wojciechowska, H., & Gajewska-Naryniecka, A. (2025) · Pharmaceuticals · doi:10.3390/ph18091406 · Cited by 48
High prevalence of p16 staining in malignant tumors
Wispelaere, N. D., Rico, S. D., Bauer, M., Luebke, A. M., Kluth, M., Büscheck, F., Hube‐Magg, C., Höflmayer, D., Gorbokon, N., Weidemann, S. A., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262877 · Cited by 41
Ochi, S., Roy, B., Prall, K., Shelton, R. C., & Dwivedi, Y. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02263-0 · Cited by 34
Walczak, K., Langner, E., Szalast, K., Makuch‐Kocka, A., Pożarowski, P., & Plech, T. (2020) · Molecules · doi:10.3390/molecules25071655 · Cited by 32
“HT-29 cells possess a mutated form of the tumor suppressor p53 gene, involved in genome stability and integrity [22].”
BackgroundEpigenetic Alterations Upstream and Downstream of p53 Signaling in Colorectal Carcinoma
Tomicic, M. T., Dawood, M., & Efferth, T. (2021) · Cancers · doi:10.3390/cancers13164072 · Cited by 36
Extracellular Vesicles as “Very Important Particles” (VIPs) in Aging
Mas‐Bargues, C., & Alique, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044250 · Cited by 37
“Secondary senescence is considered paracrine and juxtacrine senescence together [63,65].”
BackgroundErlangga, Z., Ghashang, S. K., Hamdan, I., Melk, A., Gutenbrunner, C. M., & Nugraha, B. (2023) · Human Nutrition & Metabolism · doi:10.1016/j.hnm.2023.200189 · Cited by 39
Kim, S. Y., & Cheon, J. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102446 · Cited by 36
Metadata
- Authors
- Mijit, M., Caracciolo, V., Melillo, A., Amicarelli, F., & Giordano, A.
- Affiliations
- University of Siena (IT)
- Temple University (US)
- University of L'Aquila (IT)
- Corresponding author
- Giordano, Antonio
- Venue
- Biomolecules
- Publisher
- MDPI AG
- Published
- 2020-03-08
- Volume
- 10
- Issue
- 3
- Pages
- 420
- ISSN
- 2218-273X (ISSN-L)
- PMC
- PMC7175209
- OpenAlex
- W3010215457
- Cited by
- 639
- References
- 128
- Citations by year
- 2026: 100 · 2025: 142 · 2024: 126 · 2023: 96 · 2022: 92 · 2021: 64 · 2020: 17
- FWCI
- 8.56
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Biomolecules (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Archivio Istituzionale della Ricerca - Università degli Studi della Campania "Luigi Vanvitelli" (submittedVersion)
- TUScholarShare (Temple University) (submittedVersion, cc-by)
- UniTERAMO Research Catalog (University of Teramo) (submittedVersion, other-oa)
- Use Siena air (University of Siena) (submittedVersion, other-oa)
- Funders
- H2020 Marie Skłodowska-Curie Actions (713714)
- Commonwealth of Pennsylvania, Department of Health (290228/13650)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Keywords
- p53, cellular senescence, DNA damage response, cell cycle arrest, apoptosis, genome stability, aging, antitumor immunity, senescence-associated secretory phenotype, inflammatory cytokines, tumor microenvironment, tissue dysfunction
- MeSH terms
- Animals, DNA Damage, DNA Repair, Humans, Tumor Suppressor Protein p53, Cellular Senescence, Cell Cycle Checkpoints, Cellular Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.